Nevro Corp. Accounts Receivables 2011-2026 | NVRO

Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.

Examples of accounts receivable

Customers have not paid invoices for delivered products
An advance has been paid to a supplier, but goods have not yet been received
Employees have not reported on accountable amounts
The government must refund tax overpayments
Outstanding loans issued

Importance of accounts receivable in company analysis

Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment.
Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages.
Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)

Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)

If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.

Annual Accounts Receivables Nevro Corp.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
71.9 M	79.4 M	78.9 M	70.5 M	77.7 M	82.8 M	80.7 M	67.3 M	52.8 M	22.5 M	6.61 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
82.8 M	6.61 M	62.8 M

Quarterly Accounts Receivables Nevro Corp.

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
70.6 M	74.3 M	76.9 M	79.4 M	69 M	69.4 M	65.7 M	78.9 M	69.6 M	-	63.1 M	70.5 M	63.5 M	65.4 M	66.1 M	77.7 M	77.7 M	77.7 M	77.7 M	82.8 M	82.8 M	82.8 M	82.8 M	80.7 M	80.7 M	80.7 M	80.7 M	67.3 M	67.3 M	67.3 M	67.3 M	52.8 M	52.8 M	52.8 M	52.8 M	22.5 M	22.5 M	22.5 M	22.5 M	6.61 M	6.61 M	6.61 M	6.61 M	6.6 M	6.6 M	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
82.8 M	6.6 M	58.1 M

Accounts Receivables of other stocks in the Medical devices industry

Issuer	Accounts Receivables	Price	% 24h	Market Cap	Country
EDAP TMS S.A. EDAP	18.6 M	$ 3.28	-	$ 123 M	France
Electromed ELMD	24.7 M	$ 25.74	-	$ 218 M	USA
Apollo Endosurgery APEN	15 M	-	-	$ 475 M	USA
Globus Medical GMED	679 M	$ 90.74	-	$ 12.3 B	USA
Helius Medical Technologies HSDT	117 K	$ 2.08	-	$ 1.26 M	USA
Aziyo Biologics AZYO	1.73 M	-	1.37 %	$ 20.5 M	USA
AdaptHealth Corp. AHCO	371 M	$ 13.38	-	$ 1.81 B	USA
Allied Healthcare Products AHPI	2.37 M	-	3.58 %	$ 2.21 M	USA
Avinger AVGR	1.01 M	-	-20.74 %	$ 369 K	USA
BIOLASE BIOL	5.48 M	-	-13.19 %	$ 166 K	USA
Axonics Modulation Technologies AXNX	44.8 M	-	-	$ 3.31 B	USA
Pulmonx Corporation LUNG	12.1 M	$ 1.23	-	$ 50 M	USA
BioSig Technologies BSGM	109 K	-	37.08 %	$ 85.7 M	USA
Orthofix Medical OFIX	136 M	$ 11.91	-	$ 472 M	Curacao
Conformis CFMS	9.77 M	-	-	$ 16.4 M	USA
Insulet Corporation PODD	161 M	$ 182.87	-	$ 12.9 B	USA
Cardiovascular Systems CSII	39.7 M	-	0.15 %	$ 844 M	USA
Cytosorbents Corporation CTSO	7.55 M	$ 0.6	-1.96 %	$ 37.3 M	USA
Sintx Technologies SINT	178 K	$ 2.15	-	$ 5.96 M	USA
ClearPoint Neuro CLPT	6.55 M	$ 11.08	-	$ 314 M	USA
Dynatronics Corporation DYNT	2.8 M	-	14.99 %	$ 929 K	USA
Eargo EAR	1.91 M	-	-	$ 10.2 M	USA
Stryker Corporation SYK	4.04 B	$ 321.43	-0.02 %	$ 123 B	USA
Tactile Systems Technology TCMD	43.9 M	$ 23.57	-	$ 539 M	USA
TELA Bio TELA	10.3 M	$ 0.78	-	$ 36.6 M	USA
Second Sight Medical Products EYES	455 K	-	-0.97 %	$ 54.4 M	USA
TransMedics Group TMDX	84.3 M	$ 101.26	-	$ 3.44 B	USA
Tandem Diabetes Care TNDM	165 M	$ 18.63	-	$ 1.27 B	USA
GBS GBS	595 K	-	-0.57 %	$ 7.12 M	USA
Varex Imaging Corporation VREX	157 M	$ 12.07	-	$ 500 M	USA
Butterfly Network BFLY	20.8 M	$ 5.16	-	$ 1.09 B	USA
Vivos Therapeutics VVOS	1.58 M	$ 0.85	-	$ 8.73 M	USA
Beyond Air XAIR	710 K	$ 0.51	-	$ 34.5 M	USA
OrthoPediatrics Corp. KIDS	53.8 M	$ 15.14	-	$ 355 M	USA
Delcath Systems DCTH	11.7 M	$ 10.55	-	$ 378 M	USA
Xtant Medical Holdings XTNT	17.8 M	$ 0.55	-1.78 %	$ 76.7 M	USA
Zimmer Biomet Holdings ZBH	1.48 B	$ 82.8	-	$ 16.8 B	USA
IRIDEX Corporation IRIX	7.61 M	$ 1.04	-	$ 17.6 M	USA
CONMED Corporation CNMD	248 M	$ 36.79	-	$ 1.14 B	USA